scholarly journals Bilateral Macular Edema in a Patient Treated with Tamoxifen: A Case Report and Review of the Literature

2014 ◽  
Vol 5 (3) ◽  
pp. 451-454 ◽  
Author(s):  
Paraskevas Zafeiropoulos ◽  
Panagiotis Nanos ◽  
Evangelos Tsigkoulis ◽  
Maria Stefaniotou
2021 ◽  
pp. 112067212110056
Author(s):  
Sarah M Chang ◽  
Deidre M St. Peter ◽  
Lily T Im ◽  
Wuqaas M Munir ◽  
Lisa S Schocket

Introduction: The dexamethasone (DEX) implant is an FDA approved treatment for diabetic macular edema, non-infectious posterior uveitis, and macular edema secondary to branch or central retinal vein occlusions. We describe a case of anterior chamber (AC) migration of a DEX implant in a patient with a history of congenital glaucoma and perform a review of the literature on this particular complication, summarizing the common risk factors, subsequent complications, and management options. Case description: A 46-year-old female with a history of congenital glaucoma, status post cataract extraction with insertion of intraocular lens, pars plana vitrectomy, and Baerveldt tube implant in the left eye was referred for post-operative cystoid macular edema (CME). The patient underwent insertion of a DEX implant, resulting in improvement in her CME. After the fourth implant was injected, the patient noticed a white line in her eye while looking in the mirror after doing jumping jacks. Slit lamp examination confirmed migration of the implant into the AC. Ultimately, the patient was taken to the operating room, where her implant was removed via bimanual vitrectomy through an anterior approach. Conclusion: This case report and literature review explores the ophthalmic structural changes specific to congenital glaucoma which may have predisposed this eye to anterior migration of the DEX implant. The purpose of this review is to detail the anatomic changes that may increase the risk of anterior chamber implant migration in patients with congenital glaucoma so that physicians may be aware of these risks when selecting patients for this implant.


2015 ◽  
Vol 6 (3) ◽  
pp. 289-292 ◽  
Author(s):  
Elad Moisseiev ◽  
Ala Moshiri

We report a 57-year-old patient with birdshot chorioretinopathy (BCR) who was treated with bilateral Ozurdex injections. The patient's vitritis resolved, and visual acuity improved following this treatment. This is only the second case report focused on the treatment of BCR with Ozurdex and the first to report its use for treating vitritis. A concise review of the literature on the use of intravitreal steroids for this disease is provided. This case serves to report the clinical usefulness of Ozurdex in treating posterior vitritis associated with BCR even in the absence of macular edema.


2017 ◽  
Vol 10 (1) ◽  
Author(s):  
Olga E. Makri ◽  
Foteini N. Tsapardoni ◽  
Panagiotis Plotas ◽  
Nikistratos Ifantis ◽  
Paraskevi T. Xanthopoulou ◽  
...  

2021 ◽  
pp. 646-652
Author(s):  
Charles G. Miller ◽  
Benjamin J. Kim

A 46-year-old man with a history of well-controlled hypertension presented with a central retinal vein occlusion (CRVO) in his right eye, which was complicated by cystoid macular edema. When the patient noted new visual symptoms, he was also experiencing muscle aches and easy fatiguability. A standard hypercoagulability panel failed to identify an etiology for his CRVO. However, the patient underwent COVID-19 antibody testing, which returned positive. The patient received a series of aflibercept injections for his macular edema, and his vision improved. Further study is warranted to determine if there is any association between mild infection with COVID-19 and the development of CRVO.


1999 ◽  
Vol 19 (3) ◽  
pp. 328-335
Author(s):  
Shanop Shuangshoti Shuangshoti ◽  
Samruay Shuangshoti

2015 ◽  
Vol 21 ◽  
pp. 209-210
Author(s):  
Richa Bhattarai ◽  
Bidur Dhakal ◽  
Joseph Belsky ◽  
Nadja Pedersen ◽  
Maria Jan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document